Themed collection Nanoparticle-based cancer therapies
![](https://www.rsc-cdn.org/pubs-core/2022.0.146/content/NewImages/Ajax-GA-Loader.gif)
![Open Access](https://www.rsc-cdn.org/pubs-core/2022.0.146/content/NewImages/open-access-icon-orange.png)
Nanoparticle-based delivery systems as emerging therapy in retinoblastoma: recent advances, challenges and prospects
Nanoparticles utilized in targeting retinoblastoma cells demonstrated improved uptake and intracellular internalization, sustained retention, excellent cytotoxicity, enhanced apoptosis and improved antitumor activity.
Nanoscale Adv., 2023,5, 4628-4648
https://doi.org/10.1039/D3NA00462G
![Open Access](https://www.rsc-cdn.org/pubs-core/2022.0.146/content/NewImages/open-access-icon-orange.png)
Strategies for targeted gene delivery using lipid nanoparticles and cell-derived nanovesicles
This review article discusses the latest formulation methodologies and strategies for the targeted delivery of lipid nanoparticles and cell-derived nanovesicles to achieve efficient gene transfection with minimized side effects.
Nanoscale Adv., 2023,5, 3834-3856
https://doi.org/10.1039/D3NA00198A
![Open Access](https://www.rsc-cdn.org/pubs-core/2022.0.146/content/NewImages/open-access-icon-orange.png)
Lipid-based colloidal nanoparticles for applications in targeted vaccine delivery
This review article demonstrated nucleic acid-based therapeutics and lipid nanoparticle type as a carrier of nucleic acid therapeutics for further applications of LNPs as flexible carriers in immuno-therapeutics and anti-cancer reagents.
Nanoscale Adv., 2023,5, 1853-1869
https://doi.org/10.1039/D2NA00795A
![Open Access](https://www.rsc-cdn.org/pubs-core/2022.0.146/content/NewImages/open-access-icon-orange.png)
Organic and inorganic nanomedicine for combination cancer therapies
To improve cancer treatment, various organic and inorganic nanomedicine has been studied widely combining chemo-, photodynamic-, photothermal-, radio-, and immunotherapy.
Nanoscale Adv., 2023,5, 1600-1610
https://doi.org/10.1039/D3NA00043E
![Open Access](https://www.rsc-cdn.org/pubs-core/2022.0.146/content/NewImages/open-access-icon-orange.png)
HER-2-targeted boron neutron capture therapy using an antibody-conjugated boron nitride nanotube/β-1,3-glucan complex
HER-2 targeted boron nitride nanotube was developed as a boron agent for boron neutron capture therapy.
Nanoscale Adv., 2023,5, 3857-3861
https://doi.org/10.1039/D3NA00028A
![Open Access](https://www.rsc-cdn.org/pubs-core/2022.0.146/content/NewImages/open-access-icon-orange.png)
Targeted photodynamic therapy for breast cancer: the potential of glyconanoparticles
Glyconanoparticles selectively bind to cellular targets via glycan–lectin interactions and are excellent drug-delivery systems for targeted photodynamic therapy of cancer.
Nanoscale Adv., 2023,5, 6501-6513
https://doi.org/10.1039/D3NA00544E
![Open Access](https://www.rsc-cdn.org/pubs-core/2022.0.146/content/NewImages/open-access-icon-orange.png)
Thymoquinone-loaded lipid nanocapsules with promising anticancer activity for colorectal cancer
Lipid nanocapsules was used as thymoquinone nano delivery system to treat colorectal cancer (CRC). TQ-LNCs show a suitable mean size particle and a high drug payload, inducing an early decrease in tumor growth following intratumoral administration to mice.
Nanoscale Adv., 2023,5, 5390-5398
https://doi.org/10.1039/D3NA00445G
![Open Access](https://www.rsc-cdn.org/pubs-core/2022.0.146/content/NewImages/open-access-icon-orange.png)
Chitosan-coated ultrapure silicon nanoparticles produced by laser ablation: biomedical potential in nano-oncology as a tumor-targeting nanosystem
Chitosan ultrapure silicon nanoparticles produced by femtosecond laser ablation exhibited an ideal biodistribution profile within tumor microenvironment promising their application in the nano-oncology field as tumor targeting system.
Nanoscale Adv., 2023,5, 3044-3052
https://doi.org/10.1039/D3NA00253E
About this collection
Guest Edited by Catarina Pinto Reis (University of Lisbon, Portugal), Maria Manuela Gaspar (University of Lisbon, Portugal) and Carlos A García-González (Universidade de Santiago de Compostela, Spain)
This themed collection features work covering wide ranging aspects of nanoparticle-based cancer therapy, including vaccine delivery, tumour-targeting systems, and much more.